Cargando…
Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in cancer patients and leads to a significant increase in health care costs. Cancer patients often suffer from multiple co-morbidities and have both a greater risk of VTE recurrence and bleeding compared to non-cancer patients...
Autores principales: | Frere, Corinne, Benzidia, Ilham, Marjanovic, Zora, Farge, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357110/ https://www.ncbi.nlm.nih.gov/pubmed/30634638 http://dx.doi.org/10.3390/cancers11010071 |
Ejemplares similares
-
Management of Cancer-Associated Thrombosis: An Evolving Area
por: Frere, Corinne, et al.
Publicado: (2020) -
Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges
por: Farge, Dominique, et al.
Publicado: (2019) -
Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies
por: Frere, Corinne, et al.
Publicado: (2019) -
The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis
por: Frere, Corinne, et al.
Publicado: (2022) -
Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
por: Frere, Corinne, et al.
Publicado: (2022)